2021
Changes in COVID-19-related outcomes, potential risk factors and disparities over time
Yu Y, Gu T, Valley T, Mukherjee B, Fritsche L. Changes in COVID-19-related outcomes, potential risk factors and disparities over time. Epidemiology And Infection 2021, 149: e192. PMCID: PMC8376857, DOI: 10.1017/s0950268821001898.Peer-Reviewed Original ResearchIntensive care unit admission ratePotential risk factorsHospitalisation ratesAdmission ratesIntensive care unitCOVID-19-positive cohortCOVID-19-related hospitalisationMichigan MedicineResidential-level socioeconomic characteristicsOdds ratioRisk factorsTime-stratified analysisT1 to T3Impact of potential risk factorsInvestigate temporal trendsCOVID-19-related outcomesRetrospective cohort studySocioeconomic statusRacial disparitiesCalendar timeCohort studySocioeconomic characteristicsHospitalisationBlack patientsComorbid conditions
2019
Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer
Caram M, Ross R, Lin P, Mukherjee B. Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer. JAMA Network Open 2019, 2: e192589. PMID: 31002323, PMCID: PMC6481456, DOI: 10.1001/jamanetworkopen.2019.2589.Peer-Reviewed Original ResearchConceptsMinimally symptomatic metastatic castration-resistant prostate cancerSipuleucel-TProstate cancerSymptomatic metastatic castration-resistant prostate cancerDatabase of commercially insured patientsMetastatic castration-resistant prostate cancerCastration-resistant prostate cancerAge of patientsRetrospective cohort studyFactors associated with useAssociated with patientsCommercially insured patientsPatterns of treatmentConcurrent therapyTreated patientsCohort studyMultivariate analysisCancer therapyTherapyPatientsPhysician factorsCancerBarriers to treatmentBinomial logistic regressionLogistic regression